Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Articles|May 7, 2018
Innovative Module for Pharma Labelling Increases Speed with Optimal Documentation
Author(s)Pharmaceutical Technology Editors
Herma’s new label removal unit reduces the time for discharging misprinted labels by more than half.
Advertisement
At Achema 2018, Herma will be presenting a new solution combining traceability and efficiency during the labelling of pharmaceuticals. With the new removal module, misprinted labels remain on the backing paper and are no longer discarded onto a label collecting roll.
“Thanks to our special construction, users are now able to label pharmaceuticals more efficiently and create documentation with better traceability. Especially in the case of batch changes, setting up a new format often leads to misprints. Until now, labels featuring unreadable print or wrong codes were not applied to the product but discarded onto a motorized label collecting roll. Counting and analyzing these rejected labels proved very difficult”, Ulrich Fischer, head of product management at Herma GmbH, said in a
Herma’s new machine reduces the time for discharging misprinted labels by more than half, as the complete process of applying them to a collecting roll is rendered unnecessary. Labels with insufficient quality now remain on the backing paper. For that purpose, two rounded, semi-cylindrical sliders quickly extend over the dispensing beak. Their radius is such that the label will not detach from the backing paper but remain there instead. The run of the product to be labelled is neither stopped nor slowed down. After finishing the batch, users can easily unwind the backing paper to analyze and document every misprinted label. Potential error sources can thus be identified earlier and be efficiently eliminated for future batches. Counting and analyzing the labels becomes easy.
The new label removal unit can be used with the wrap-around labelling machines HERMA 152E and HERMA 132M. The compact wrap-around labelling system 152E covers a wide range of product dimensions without requiring any format sets and features full pharmaceutical equipment, including modules for variable data printing, for monitoring print and codes, and for label presence checks, and the corresponding ejection unit.
The innovative label removal unit will be shown at the ACHEMA booth in a HERMA 152E wrap-around labelling system.
Source:
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement